LET'S BE BUDS

Bud & Mary’s Batch Extracts Sponsors 2025 Rooster Art Fest

Batch, the acclaimed extracts brand of Bud & Mary’s, is bringing the inspiration to the 2025 Rooster Art Fest, sponsoring a pair of live art demonstrations from Denver artists Joe Palec and Patrick Kane McGregor during the annual event at ReelWorks Denver on Sat., Sept. 6. 

Bud & Mary’s Launches TheMyx

FOR IMMEDIATE RELEASE Bud & Mary’s Launches TheMyx: The First Patented, Fast-Acting THC Dissolvable  A Scientifically Backed, Versatile, and Discreet Way to Consume Cannabis  DENVER (February 25, 2025) – Bud & Mary’s, the only regulated cannabis operator with a Schedule I DEA license for medical research, is transforming cannabis consumption with TheMyx, a patented THC dissolvable designed for faster onset, consistent dosing, higher bioavailability, and unmatched versatility.  Developed with patented technology originally designed for FDA-approved cannabis-derived therapeutics, TheMyx represents a major advancement in cannabinoid delivery. Its unique emulsification process breaks down THC into ultra-small, encapsulated particles that naturally mix with water—and any other food or beverage—leading to improved solubility and stability. By pre-emulsifying the cannabinoids before consumption, TheMyx allows the body to absorb THC more efficiently, bypassing the digestion delays seen with traditional edibles.  “TheMyx is a true innovation in cannabis science,” said Dr. Duncan Mackie, Director of Pharmacology & Experimental Therapeutics at Bud & Mary’s. “Most THC products require the body to break down oils before absorption, which can create inconsistencies in onset time and effectiveness. With TheMyx, we’ve done that work in advance, allowing for faster, more predictable effects.”  This breakthrough product is the only patented dissolvable THC powder on the market (Patent# US-11857589-B2), reinforcing Bud & Mary’s leadership in cannabis research and innovation. As a company committed to science-backed cannabinoid solutions, Bud & Mary’s continues to push the boundaries of cannabis technology, offering consumers and patients access to cleaner, more effective, and more convenient products.  Unlike traditional tinctures, oils, or edibles that require fat-based digestion, TheMyx utilizes a proprietary self-emulsifying process that allows cannabinoids to be quickly absorbed into the bloodstream. This means faster effects and a more consistent experience, eliminating the variability often associated with oral cannabis consumption.  TheMyx dissolves seamlessly into any beverage or food without altering taste, texture, or carbonation. Whether stirred into coffee, added to a favorite seltzer, blended into a smoothie, or sprinkled over a meal, TheMyx provides a discreet, controlled, and mess-free alternative to traditional cannabis formats. Unlike liquid-based dissolvables, which are limited to mixing with other liquids, TheMyx can be added to virtually any consumable, offering consumers unparalleled flexibility.  Portability and precision are also key advantages. TheMyx comes in slim, single-dose packets that fit easily into a wallet or purse, making it an ideal option for on-the-go use. Each packet delivers a measured amount of THC, ensuring consumers can accurately control their intake without the guesswork associated with other formats.  TheMyx is now available in Colorado and Iowa with other markets launching in the coming months. Images are available at this link. For more information or to schedule an interview please contact Shawna Seldon McGregor at shawna@themaverickpr.com or 917-971-7852.   Bud & Mary’s: Crafted for You, Powered by Science. At Bud & Mary’s, we take a science-driven approach to crafting premium cannabis products designed for every individual. From our best-selling BATCH vape cartridges and CURATED flower to our innovative water-soluble TheMyx powder and wellness-focused brands Become and NUO, every product is developed with care, precision, and an unwavering commitment to quality. Locally grown and rigorously tested, Bud & Mary’s products meet the highest standards of safety, consistency, and excellence. What started in a Midwest barn in 1961 has evolved into a multi-billion-dollar company serving Colorado, Michigan, Iowa, Missouri, and beyond. Through it all, we’ve remained true to our roots—family-driven, people-focused, and dedicated to pushing the boundaries of cannabis innovation. For more information, visit BudMary.com. Continue the conversation on Facebook, Instagram, X, LinkedIn and TikTok.

Bud & Mary’s Advances Cannabis Research to Improve Therapeutic Applications and Bridge Gaps in Wellness Efficacy

FOR IMMEDIATE RELEASE Bud & Mary’s Advances Cannabis Research to Improve Therapeutic Applications and Bridge Gaps in Wellness Efficacy Scientific studies on neurodegenerative diseases, sleep, and consumer products aim to set new standards for safety, accuracy, and medical potential DENVER (February 13, 2025) – MedPharm DBA Bud & Mary’s, a federally licensed cannabis research and pharmaceutical development company, continues to lead scientific advancements in cannabis-based therapeutics as the only U.S. company with a DEA Schedule I licensed research facility. With several active studies addressing neurodegenerative diseases such as Alzheimer’s, sleep health and product consistency, the company remains at the forefront of industry innovation. “Our research tackles key challenges in cannabis science, from investigating how cannabinoid-based therapies can treat neurodegenerative diseases to exploring potential benefits for sleep quality and anxiety,” said Dr. Duncan Mackie, Director of Pharmacology & Experimental Therapeutics at Bud & Mary’s. “By applying rigorous scientific methods and working with leading academic institutions, we are building the data necessary to inform regulatory decisions, guide industry standards, and develop the future of cannabis-based therapeutics.” Bud & Mary’s latest research initiatives include: This research has produced active patents for Bud & Mary’s including Water-Based Extraction and Purification Processes for Cannabinoid Acids; Hybrid Extraction Process for Cannabinoids and Related Methods; Brain Health Formulation; Pharmaceutical Packaging Device; Self-Emulsifying Anhydrous Intradermal Depot Gel; Water Soluble, Powdered Cannabinoid and/or Terpene Extract. With a DEA Schedule I licensed research facility, an ISO17025-accredited analytical laboratory, and a cGMP and GACP-certified production site, Bud & Mary’s is at the forefront of cannabis research. Its efforts include partnerships with Colorado State University Pueblo’s Institute of Cannabis Research; University of Colorado’s CU-Change; CU Anschutz’s Colorado School of Public Health; Northwestern University Feinberg School of Medicine’s Department of Physical Medicine & Rehabilitation; Edward Hines Jr. VA Research Service & the Center of Innovation for Complex Chronic Health Care; University of Illinois Chicago Center for Dissemination and Implementation Science; Colorado State University’s Department of Psychology; University of Iowa College of Public Health’s Cannabis and Older Person Study (COPS) and the Institute for Clinical and Translational Science. Supporting a broader conversation on evidence-based cannabis research and regulation, Dr. Mackie will speak at UC Anschutz in the Skaggs School of Pharmacy and Pharmaceutical Sciences’ Innovation and Entrepreneurship Monthly Seminar Series during the Faculty Forum on Friday, Feb. 21, at 1:30pm. Bud & Mary’s will also participate in the First Annual Dinner for the Advancement of Cannabis Science on Tuesday, February 25, supporting a broader conversation on evidence-based cannabis research and regulation. The company’s support aligns with its commitment to fostering collaboration between researchers, policymakers, and industry leaders. For more information on Bud & Mary’s research initiatives or to schedule an interview, contact Shawna Seldon McGregor at 917-971-7852 or shawna@themaverickpr.com.  Bud & Mary’s: Crafted for You, Powered by Science. At Bud & Mary’s, we take a science-driven approach to crafting premium cannabis products designed for every individual. From our best-selling BATCH vape cartridges and CURATED flower to our innovative water-soluble TheMyx powder and wellness-focused brands Become and NUO, every product is developed with care, precision, and an unwavering commitment to quality. Locally grown and rigorously tested, Bud & Mary’s products meet the highest standards of safety, consistency, and excellence. Through it all, we’ve remained true to our roots—family-driven, people-focused, and dedicated to pushing the boundaries of cannabis innovation. For more information, visit BudMary.com. Continue the conversation on Facebook, Instagram, X, LinkedIn and TikTok.

Come back again!

You must be at least 21 or be a valid medical cardholder to enter this site.

Hello!

Are you at least 21 years old, or a valid medical cannabis cardholder?

Yes
No